AI-generated summary
This review examines photobiomodulation therapy, which uses red and near-infrared light, for chronic wound healing, combining molecular mechanisms with clinical evidence. The authors report that therapy delivered with lasers or LEDs at optimum dosages was associated with faster wound closure, more collagen synthesis, reduced inflammation and pain relief across several wound types. They also note that literature is fragmented and dosimetric protocols are heterogeneous.
- Who or what was studied
- Patients with chronic wounds, including diabetic, venous ulcers, pressure injuries and severe burns
- Wavelengths
- 450, 950 nm
- Limits stated in the abstract
- The abstract notes fragmented literature, heterogeneity in dosimetric protocols, and does not report the number of studies included.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 450-950 nm
- Energy density (fluence)
- 20 J/cm2
- Power density (irradiance)
- 500 mW/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Near-infrared, Collagen, Reactive oxygen species, Heterogeneity, Wound healing, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.